Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study

BACKGROUND: Long-acting beta-agonists were one of the first-choice bronchodilator agents for stable chronic obstructive pulmonary disease. But the impact of long-acting beta-agonists on mortality was not well investigated. METHODS: National Emphysema Treatment Trial provided the data. Severe and ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Horita, Nobuyuki, Miyazawa, Naoki, Morita, Satoshi, Kojima, Ryota, Kimura, Naoko, Kaneko, Takeshi, Ishigatsubo, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674977/
https://www.ncbi.nlm.nih.gov/pubmed/23725215
http://dx.doi.org/10.1186/1465-9921-14-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674977/
https://www.ncbi.nlm.nih.gov/pubmed/23725215
http://dx.doi.org/10.1186/1465-9921-14-62

Ejemplares similares